Replies to post #32415 on Regen BioPharma Inc (RGBP)

[SanDiegoAlan]

Actually trying to put a drug through an FDA phase 1 trial is way beyond the abilities of Koos so he just dropped it and went on to NR2F6.

[Goldstrike]

Whatever happened?
They switched gears to their current small molecule research on NR2F6. Here's a recent independent publication article on this from just two weeks ago: https://www.nature.com/articles/s41467-018-04004-2
Seems NR2F6 could be potentially a super huge mega blockbuster!!!